Establishment of Rabbit Liver VX2 Tumor Model Using Percutaneous Puncture Inoculation of Tumor Fragment Guided and Evaluated by Ultrasonography

Abstract

The aim of the present study is to evaluate a method of establishing model of rabbit liver VX2 tumor using percutaneous puncture inoculation of tumor fragment guided by ultrasonography. VX2 tumor fragments were implanted into the liver of 13 New Zealand white rabbits flushed by 1 mL normal saline through percutaneous puncture needle guided by ultrasonography. Conventional ultrasonography and contrast-enhanced ultrasonography (CEUS) were performed 14 days after inoculation, and then the rabbits were sacrificed and pathologically examined. The success rate of inoculation was 100%. The average size of liver VX2 tumor was 1.7 cm×1.3 cm, CEUS of VX2 liver tumors showed the “rapid wash-in and wash-out” vascular pattern. There were significant differences between VX2 tumors and liver parenchyma in quantitative parameters of A, k and A × k (P<0.05), which meant that VX2 liver tumors were characterized by more blood flow volume and faster blood velocity than liver parenchyma. Tumor fragment flushed by normal saline into the liver through a needle may be a promising method for the induction of a hepatic tumor. And CEUS can be used for accurately assessing angiogenesis and blood perfusion of VX2 tumors.

Keywords

liver / VX2 tumor / rabbit / ultrasonography / contrast-enhanced ultrasonography

References

[1] HeJ, GuD, WuX, et al.. Major causes of death among men and women in China. N Engl J Med, 2005, 353(11): 1124-1134

[2] KawanoY, SasakiA, KaiS, et al.. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol, 2008, 15(6): 1670-1676

[3] ScartozziM, BaroniGS, FaloppiL, et al.. Transarterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large monoinstitutional analysis. J Exp Clin Cancer Res, 2010, 29: 164

[4] NumataK, FukudaH, OhtoM, et al.. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent. Eur J Radiol, 2010, 75(2): e67-75

[5] MorozP, MetcalfC, GrayBN. Histologic analysis of liver tissue following hepatic arterial infusion of ferromagnetic particles in a rabbit tumour model. Biometals, 2003, 16(3): 455-464

[6] GeorgesE, BreitburdF, JibardN, et al.. Two Shope papillomavirus-associated VX2 carcinoma cell lines with different levels of keratinocyte differentiation and transplantability. J Virol, 1985, 55(1): 246-250

[7] LiC, WangW, DingH, et al.. Value of contrast-enhanced sonography in the diagnosis of peripheral intrahepatic cholangiocarcinoma. J Clin Ultrasound, 2011, 39(8): 447-453

[8] GuptaT, VirmaniS, NeidtTM, et al.. MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility study. Radiology, 2008, 249(3): 845-854

[9] LeeKH, LiapiE, VenturaVP, et al.. Evaluation of different calibrated spherical polyvinyl alcohol microspheres in transcatheter arterial chemoembolization: VX2 tumor model in rabbit liver. J Vasc Interv Radiol, 2008, 19(7): 1065-1069

[10] SunJH, ZhangYL, NieCH, et al.. Considerations for two inoculation methods of rabbit hepatic tumors: Pathology and image features. Exp Ther Med, 2012, 3(3): 386-390

[11] LiuYJ, RenWD, LiuCG, et al.. Contrast-enhanced ultrasonography of the rabbit VX2 tumor model: analysis of vascular pathology. Oncol Lett, 2012, 4(4): 685-690

[12] WuH, PatelRB, ZhengY, et al.. Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model. Ultrasound Med Bio, 2012, 38(3): 433-453

[13] CabibboG, EneaM, AttanasioM, et al.. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology, 2010, 51(4): 1274-1283

[14] SonodaA, NittaN, OhtaS, et al.. Controlled release and antitumor effect of pluronic F127 mixed with cisplatin in a rabbit model. Cardiovasc Intervent Radiol, 2010, 33(1): 135-142

[15] HänslerJ, NeureiterD, WasserburgerM, et al.. Percutaneous US-guided radiofrequency ablation with perfused needle applicators: improved survival with the VX2 tumor model in rabbits. Radiology, 2004, 230(1): 169-174

[16] VirmaniS, RheeTK, RyuRK, et al.. Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors. J Vasc Interv Radiol, 2008, 19(10): 1483-1489

[17] WilsonSR, GreenbaumLD, GoldbergBB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles?. AJR Am J Roentgenol, 2009, 193(1): 55-60